Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 937 entries
Sorted by: Best Match Show Resources per page
[Clinical nursing. 6. Outlines of clinical training in nursing of adults. 4].

[Kango gijutsu] : [Nursing technique]

Suzuki M, Tsuboi Y.
PMID: 4494012
Kango Gijutsu. 1974 Feb;20(2):147-55.

No abstract available.

[Management of hypertension for the local population].

[Hokenfu zasshi] The Japanese journal for public health nurse

Nakamura E, Tsuboi T.
PMID: 4492897
Hokenfu Zasshi. 1973 Nov;29(11):878-83.

No abstract available.

[Total gastrectomy].

Geka chiryo. Surgical therapy

Sato H, Onishi M, Otsubo Y, Makino K.
PMID: 6014128
Geka Chiryo. 1966 Mar;14(3):270-90.

No abstract available.

Immunoglobulin G4-related sclerosing cholecystitis presenting as gallbladder cancer: a case report.

Surgical case reports

Takahashi K, Ito H, Katsube T, Tsuboi A, Hashimoto M, Ota E, Mita K, Asakawa H, Hayashi T, Fujino K, Okamoto S.
PMID: 26943444
Surg Case Rep. 2015 Dec;1(1):120. doi: 10.1186/s40792-015-0123-4. Epub 2015 Dec 03.

Immunoglobulin G4 (IgG4)-related sclerosing disease is a systemic inflammatory syndrome, and an understanding of its characteristics is currently evolving. IgG4-related cholecystitis is a manifestation of IgG4-related sclerosing disease in the gallbladder. This case report describes the clinical, radiographic, and...

Sudden Onset of Brain Metastasis despite the Use of Vemurafenib for Another Metastatic Lesion in Malignant Melanoma Patients.

Case reports in oncology

Imafuku K, Yoshino K, Yamaguchi K, Tsuboi S, Ohara K, Hata H.
PMID: 28512412
Case Rep Oncol. 2017 Apr 04;10(1):290-295. doi: 10.1159/000461576. eCollection 2017.

Vemurafenib is an inhibitor of the BRAF mutation and has been approved by the Food and Drug Administration as a treatment option for patients with unresectable melanoma without brain metastasis. In the literature, vemurafenib has been reported to be...

Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events.

Case reports in oncology

Imafuku K, Yoshino K, Yamaguchi K, Tsuboi S, Ohara K, Hata H.
PMID: 28512413
Case Rep Oncol. 2017 Apr 04;10(1):296-300. doi: 10.1159/000463379. eCollection 2017.

Nivolumab is a recently approved medication for the treatment of unresectable malignant melanoma. Many immune-related adverse events (irAEs) associated with nivolumab have been reported, such as pneumonitis, hepatitis, dermatitis, and thyroiditis. Prednisolone can effectively treat irAEs. However, it is...

Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.

Journal of diabetes investigation

Nino A, Okuda I, Wilson TH, Yue L, Nakajima H, Tsuboi M, Carr MC, Seino Y.
PMID: 28921915
J Diabetes Investig. 2017 Sep 16; doi: 10.1111/jdi.12749. Epub 2017 Sep 16.

AIMS/INTRODUCTION: The present phase 3, randomized, double-blind 24-week study with extension to 1 year assessed the efficacy and safety of albiglutide compared with placebo in Japanese patients with type 2 diabetes mellitus inadequately controlled by diet and exercise with...

Giving social support to outside family may be a desirable buffer against depressive symptoms in community-dwelling older adults: Japan gerontological evaluation study.

BioPsychoSocial medicine

Tsuboi H, Hirai H, Kondo K.
PMID: 27226808
Biopsychosoc Med. 2016 May 24;10:18. doi: 10.1186/s13030-016-0064-6. eCollection 2016.

BACKGROUND: Depression is the leading cause of impaired quality of life and burden upon societies. Social supports can buffer against depressive symptoms effectively. The aim of this study is to determine the type of social support to have a...

Risk of perforation in balloon dilation associated with steroid injection for preventing esophageal stricture after endoscopic submucosal dissection.

Endoscopy international open

Tsujii Y, Hayashi Y, Kawai N, Yamada T, Yamamoto K, Hayashi S, Yoshii S, Nagai K, Inoue T, Nishida T, Iijima H, Mita E, Inoue A, Takehara T.
PMID: 28670613
Endosc Int Open. 2017 Jul;5(7):E573-E579. doi: 10.1055/s-0043-110077. Epub 2017 Jun 23.

BACKGROUND AND STUDY AIMS:  Endoscopic local steroid injection (LSI) has been used to prevent esophageal strictures after endoscopic submucosal dissection (ESD) for superficial esophageal neoplasms (SENs). This study aimed to evaluate the safety and efficacy of LSI therapy.PATIENTS AND...

Fatigue-related differences in erector spinae between prepubertal children and young adults using surface electromyographic power spectral analysis.

Journal of back and musculoskeletal rehabilitation

Tanina H, Nishimura Y, Tsuboi H, Sakata T, Nakamura T, Murata KY, Arakawa H, Umezu Y, Tajima F.
PMID: 27232083
J Back Musculoskelet Rehabil. 2016 May 20; doi: 10.3233/BMR-160705. Epub 2016 May 20.

BACKGROUND: The erector spinae is more resistant to fatigue in adult women than men. However, no study has reported the sex differences in back muscle fatigue in children.OBJECTIVE: The aim of this study was to evaluate the fatigability of...

A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis.

Neuro-oncology practice

Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI.
PMID: 27833757
Neurooncol Pract. 2016 Dec;3(4):272-280. doi: 10.1093/nop/npv064. Epub 2016 Jan 07.

BACKGROUND: Brain radiation necrosis (BRN) can be a complication of radiotherapy for primary and secondary brain tumors, as well as head and neck tumors. Since vascular endothelial growth factor (VEGF) is also a vascular permeability factor in the brain,...

Glomerulopathy Associated With Moderate Obesity.

Kidney international reports

Okabayashi Y, Tsuboi N, Sasaki T, Haruhara K, Kanzaki G, Koike K, Miyazaki Y, Kawamura T, Ogura M, Yokoo T.
PMID: 29142929
Kidney Int Rep. 2016 Aug 12;1(4):250-255. doi: 10.1016/j.ekir.2016.08.006. eCollection 2016 Nov.

INTRODUCTION: Obesity-related glomerulopathy is an established secondary glomerular disease that may occur in obese individuals with a body mass index (BMI) of ≥30 kg/mMETHODS: A total of 20 patients with grade 1 obesity (25 ≤ BMI < 30 kg/mRESULTS:...

Showing 1 to 12 of 937 entries